Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
The peptide raises production of growth factors, including vascular endothelial growth factor (VEGF), which drives new blood vessel formation, and epidermal growth factor (EGF), which supports cell growth and differentiation
Once stabilized, treatments may be spaced every 24 weeks for maintenance
Secondary osteoporosis: obesity, diabetes, long-term sedentary, hormone drugs, excessive fat reduction, etc., interfere with calcium and phosphorus metabolism, inhibit osteogenesis, promote osteoclasis, and cause bone loss
This high potency has been independently confirmed and represents a well-characterized pharmacological property
A history of regulatory challenges FDA investigators first began documenting problems with Empowers sterile drug production processes in 2015, when the company did not thoroughly investigate how a batch of weight loss injectables became contaminated with bacteria, records say
US$ 27.46
US$ 27.33
US$ 29.56
US$ 20.86
US$ 28.03
US$ 21.47
US$ 22.01
US$ 20.94